CAPTRUST Financial Advisors’s NantHealth, Inc NH Stock Holding History

CAPTRUST Financial Advisors’s Portfolio NH Stock Details NH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-27	Closed	–	–	4542
2022 Q2	$0	Buy	+27	New	+$252	﹤0.01%	5265

Other funds holding NH

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAPTRUST Financial Advisors's NH Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of NantHealth, Inc (NH) in Q3 2022, closing a stake of 27 shares.

CAPTRUST Financial Advisors first reported a position in NH in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 38 funds tracked by Wall St. Rank hold NH as of Q3 2022.

CAPTRUST Financial Advisors reported no remaining NantHealth, Inc position as of Q3 2022 after selling out during the quarter.
CAPTRUST Financial Advisors sold 27 NantHealth, Inc shares in Q3 2022.
CAPTRUST Financial Advisors first reported a position in NantHealth, Inc in Q2 2022 and held it in 1 quarter.
CAPTRUST Financial Advisors's NantHealth, Inc position peaked at $0 in Q2 2022.
38 funds tracked by Wall St. Rank held NantHealth, Inc as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.